万维提示：
1、该刊只有国际刊号。
2、投稿方式：在线投稿。
3、官网网址（主办单位杂志社进入）：
https://journals.muhn.edu.cn/jad/home
https://journals.lww.com/joad/pages/default.aspx
4、投稿系统：https://review.jow.medknow.com/jad
5、主办单位杂志社官网：
https://journals.muhn.edu.cn/qks
6、官网邮箱：
editor@jadweb.org；jadweb@yahoo.com
7、官网电话：0898-66890465
8、期刊刊期：以Continuous publication形式出刊，一年出版1卷。
2025年6月11日星期三
《急性病杂志（英文）》作者须知
（Journal of Acute Disease）
【官网信息】
Information For Authors
The Editorial Process
A manuscript will be reviewed for possible publication with the understanding that it is being submitted to Journal of Acute Disease alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the Journal of Acute Disease readers are also liable to be rejected at this stage itself.
Manuscripts received from Editorial Board members will be screened by the Editor in Chief and sent to external peer reviewers. The editorial board members who are authors will be excluded from publication decisions.
Manuscripts that are found suitable for publication in Journal of Acute Disease are sent to two or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but this is not mandatory. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other's identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers' comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.
Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within three days. It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online. To achieve faster and greater dissemination of knowledge and information, the journal publishes articles online as 'Ahead of Print' immediately on acceptance.
Processes for appeals
The authors do have the right to appeal if they have a genuine cause to believe that the editorial board has wrongly rejected the paper. If the authors wish to appeal the decision, they should email the editorial office (email: editor@jadweb.org) explaining in detail the reason for the appeal. The appeals will be acknowledged by the editorial office and will be investigated in an unbiased manner. The processing of appeals will be done within 6 – 8 weeks. While under appeal, the said manuscript should not be submitted to other journals. The final decision rests with the Editor in Chief of the journal. Second appeals are not considered.
Anti-Plagiarism
Plagiarism includes duplicate publication of the author's own work, in whole or in part without proper citation or mispresenting other's ideas, words, and other creative expression as one's own. The Journal follows strict anti-plagiarism policy. All manuscripts submitted to Journal of Acute Disease undergoes plagiarism check with commercially available software. Based on the extent of plagiarism, authors may be asked to address any minor duplication, or similarity with the previous published work. If plagiarism is detected after publication, the Journal will investigate. If plagiarism is established, the journal will notify the authors' institution and funding bodies and will retract the plagiarised article. To report plagiarism, contact the journal office (email: editor@jadweb.org).
Clinical trial registry
Journal of Acute Disease would publish clinical trials that have been registered with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable: https://ctri.nic.in/Clinicaltrials/login.php; http://www.clinicaltrials.gov/; http://isrctn.org/; and http://www.umin.ac.jp/ctr. This is applicable to clinical trials that have begun enrollment of subjects in or after June 2018. Clinical trials that have commenced enrollment of subjects prior to June 2018 would be considered for publication in Journal of Acute Disease only if they have been registered retrospectively with clinical trial registry that allows unhindered online access to public without charging any fees.
Authorship Criteria
Authorship credit should be based only on substantial contributions to each of the three components mentioned below:
1. Concept and design of study or acquisition of data or analysis and interpretation of data;
2. Drafting the article or revising it critically for important intellectual content; and
3. Final approval of the version to be published.
Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors. The journal prescribes a maximum number of authors for manuscripts depending upon the type of manuscript, its scope and number of institutions involved (vide infra). The authors should provide a justification, if the number of authors exceeds these limits.
......
更多详见：
https://journals.lww.com/JOAD/Pages/informationforauthors.aspx
